[HTML][HTML] Real-world experience of vedolizumab use in Colombian patients with inflammatory bowel disease—EXVEDOCOL
V Parra, S Cifuentes, S Avendaño, EP de León… - Gastroenterología y …, 2024 - Elsevier
[[[[en]]] Abstract Background: Real-world studies about the effectiveness and safety of
vedolizumab (VDZ) in the treatment of inflammatory bowel disease (IBD) in Latin America …
vedolizumab (VDZ) in the treatment of inflammatory bowel disease (IBD) in Latin America …
Washed microbiota transplantation combined with biological agents promotes histological remission in refractory severe ulcerative colitis with recurrent intestinal …
Q Wu, LS Yang, HL Huang, YF Li, YJ Zhou… - Arab Journal of …, 2024 - Elsevier
Ulcerative colitis (UC) is a chronic non-specific colitis disease. In recent years, fecal
microbiota transplantation (FMT), including improved washed microbiota transplantation …
microbiota transplantation (FMT), including improved washed microbiota transplantation …
Biyolojik tedavi alan hastalarda potansiyel ilaç-ilaç etkileşmelerinin araştırılması
B Huseynov - 2024 - acikerisim.uludag.edu.tr
Biyolojik ajanlar immünomodülatör ilaçlar olup klinikte son 20 yıldır giderek artan şekilde
kullanılmaktadırlar. Başlıca biyolojik ajanlar; Anti Tümör Nekrozis Faktör (TNF) ajanlar …
kullanılmaktadırlar. Başlıca biyolojik ajanlar; Anti Tümör Nekrozis Faktör (TNF) ajanlar …
[PDF][PDF] PROTOCOLO DE INDICACIONES Y MANEJO DE FÁRMACOS BIOLÓGICOS EN LA ENFERMEDAD INFLAMATORIA INTESTINAL EN POBLACIÓN ADULTA
CJG PUYUELO, FG GARCÍA, MTA VILLARINO… - Protocolos del Hospital … - researchgate.net
• Evaluación anual de continuación de tratamiento.• Evaluación bianual por endoscopia o
imagen una vez alcanzada la remisión.• Mantoux anual o bianual (si previamente …
imagen una vez alcanzada la remisión.• Mantoux anual o bianual (si previamente …